Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adolescent Age
20%
Antiretroviral Therapy
20%
Antiretroviral Therapy Initiation
40%
Asia
100%
Asian Cohort
20%
CD4 Count
20%
Child Morbidity
20%
Clinical Staging
20%
Competing Risks
20%
Cumulative Incidence
20%
Disease-related
100%
Drug Toxicity
20%
Early Adolescence
20%
HIV Diagnosis
20%
HIV Transmission
100%
HIV Viral Load
20%
Hospitalization
60%
Immune System
20%
Immunodeficiency
20%
Infectious Events
20%
Infectious Morbidity
20%
Inflammation
20%
Late Adolescence
20%
Long-acting Antiretroviral Therapy
20%
Morbidity Rate
40%
Non-infectious
40%
Overall Morbidity
60%
Perinatally HIV-infected Adolescents
100%
Poisson Regression Analysis
20%
Staging Criteria
20%
System Damage
20%
Systemic Infection
20%
Time-to-event
20%
Treatment-related
20%
Treatment-related Morbidity
100%
U.S. National Institutes of Health
20%
Virologic Control
20%
World Health Organization
20%
Medicine and Dentistry
Acquired Immune Deficiency Syndrome
7%
Adolescence
100%
Antiretroviral Therapy
30%
Cumulative Incidence
7%
Diseases
100%
Division
7%
Drug Toxicity
7%
Human Immunodeficiency Virus
53%
Human Immunodeficiency Virus Infection
100%
Immune Deficiency
7%
Immune System
7%
Inflammation
7%
Morbidity
100%
Regression Analysis
7%
Sepsis
7%
Biochemistry, Genetics and Molecular Biology
Adolescence
100%
CD4 Lymphocyte Count
7%
Drug Toxicity
7%
Human Immunodeficiency Virus
100%
Morbidity
100%
Virus Load
7%
Neuroscience
CD4
12%
Human Immunodeficiency Virus
100%
Regression Analysis
12%